Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
One task, one interaction, one pair, experts advocate
Marks significant milestone for breakthrough biologic to treat rare blood cancers
The company will address the observations and respond to the U.S. FDA within the stipulated timeframe
Subscribe To Our Newsletter & Stay Updated
